SAN DIEGO--(BUSINESS WIRE)--Santarus, Inc. (NASDAQ: SNTS), a specialty pharmaceutical company, today announced that it has reached agreement with Comerica Bank to increase its revolving line of credit to $25 million and to extend the maturity date to July 11, 2011. Santarus entered into its first line of credit with Comerica in July 2006 with an original maturity date of July 28, 2009. Santarus will make interest-only payments on any draws from the line of credit, and all principal drawn during the term of the loan facility is due and payable at the maturity date. Interest on outstanding indebtedness under the credit facility is at either Comerica’s prime rate plus one-half percent (0.5%), or the LIBOR rate plus three percent (3.00%), at Santarus’ option.
